U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu) AND Long QT syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 24, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000631723.6

Allele description [Variation Report for NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)]

NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.1814C>T (p.Pro605Leu)
HGVS:
  • NC_000007.14:g.150951579G>A
  • NG_008916.1:g.31348C>T
  • NM_000238.4:c.1814C>TMANE SELECT
  • NM_001204798.2:c.794C>T
  • NM_001406753.1:c.1526C>T
  • NM_001406755.1:c.1637C>T
  • NM_001406756.1:c.1526C>T
  • NM_001406757.1:c.1514C>T
  • NM_172056.3:c.1814C>T
  • NM_172057.3:c.794C>T
  • NP_000229.1:p.Pro605Leu
  • NP_000229.1:p.Pro605Leu
  • NP_001191727.1:p.Pro265Leu
  • NP_001393682.1:p.Pro509Leu
  • NP_001393684.1:p.Pro546Leu
  • NP_001393685.1:p.Pro509Leu
  • NP_001393686.1:p.Pro505Leu
  • NP_742053.1:p.Pro605Leu
  • NP_742053.1:p.Pro605Leu
  • NP_742054.1:p.Pro265Leu
  • NP_742054.1:p.Pro265Leu
  • LRG_288t1:c.1814C>T
  • LRG_288t2:c.1814C>T
  • LRG_288t3:c.794C>T
  • LRG_288:g.31348C>T
  • LRG_288p1:p.Pro605Leu
  • LRG_288p2:p.Pro605Leu
  • LRG_288p3:p.Pro265Leu
  • NC_000007.13:g.150648667G>A
  • NM_000238.3:c.1814C>T
  • NM_172056.2:c.1814C>T
  • NM_172057.2:c.794C>T
  • NR_176254.1:n.2222C>T
  • NR_176255.1:n.1095C>T
  • Q12809:p.Pro605Leu
Protein change:
P265L
Links:
UniProtKB: Q12809#VAR_074844; dbSNP: rs199472938
NCBI 1000 Genomes Browser:
rs199472938
Molecular consequence:
  • NM_000238.4:c.1814C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001204798.2:c.794C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406753.1:c.1526C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406755.1:c.1637C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406756.1:c.1526C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406757.1:c.1514C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.1814C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172057.3:c.794C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Long QT syndrome (LQTS)
Identifiers:
MONDO: MONDO:0002442; MeSH: D008133; MedGen: C0023976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000752811Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 24, 2017)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndrome.

Anderson CL, Kuzmicki CE, Childs RR, Hintz CJ, Delisle BP, January CT.

Nat Commun. 2014 Nov 24;5:5535. doi: 10.1038/ncomms6535.

PubMed [citation]
PMID:
25417810
PMCID:
PMC4243539

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000752811.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change causes the KCNH2 protein to be trafficking-deficient (PMID: 25417810). This variant has not been reported in the literature in individuals with KCNH2-related disease. ClinVar contains an entry for this variant (Variation ID: 67284). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 605 of the KCNH2 protein (p.Pro605Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024